Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437732 · ClinicalTrials.gov registry record · NA
Apioc Presbyopic Contact Lens
A NA study, sponsored by Lentechs.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04437732: Completed NA study, sponsored by Lentechs.
NCT04437732 is a NA study that has completed, run by Lentechs. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04437732, a NA study, has completed, sponsored by Lentechs.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).
Primary Outcome
LogMAR visual acuity
Interventions
- DEVICE Apioc-P and Apioc-PT Contact Lens Design
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2021-06-09 |
| Phase | NA |
What the finished NCT04437732 record still lists
NCT04437732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Apioc-P and Apioc-PT Contact Lens Design is the first listed.
NCT04437732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04437732 about?
NCT04437732 is a clinical study titled "Apioc Presbyopic Contact Lens". In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).
What is the current status of trial NCT04437732?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2019-11-11. Estimated completion is 2021-06-09.
What interventions are being tested in trial NCT04437732?
The interventions under investigation include: Apioc-P and Apioc-PT Contact Lens Design (DEVICE).
Who is sponsoring clinical trial NCT04437732?
This trial is sponsored by Lentechs, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04437732's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI